This product includes the webinar and CME/CMLE credit.


Description:

This webinar will review the most recent revision of the World Health Organization (WHO) classification of acute leukemia with a particular focus on acute myeloid leukemia. A summary of changes to the classification of lymphoblastic leukemia/lymphoma and acute leukemias of ambiguous lineage will also be summarized.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).


Speaker: Daniel A. Arber, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Intermediate

Last day to purchase course and claim credit: January 22, 2021

Maxiumum CME/CMLE credit available: 1.0


How to claim credit: To earn CME/CMLE credit, all learners must watch the webinar and then complete the online survey. To access the online survey, click "Submit credit" on the course homepage, or click on "My Credit" on the menu to the left.

AMA PRA Category 1 Credit(s)™

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity. 

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

 

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

 
Course Information
Course Date:
January 22, 2018
Course Objectives
  • Distinguish genetic mutations that define disease entities versus prognostic markers in acute leukemia.
  • Describe genetic abnormalities that define new disease categories of acute leukemia.
  • Apply diagnostic criteria for acute leukemia using a combination of clinical information, morphology, immunophenotyping and molecular genetic testing.
Update on the 2016 WHO Classification of Acute Leukemias
Speaker Information
Daniel A. Arber MD  [ view bio ]
Individual topic purchase: Selected
American Medical Association
Continuing Medical Education: 1.00
American Society for Clinical Pathology
CMLE: 1.00
Products
Arber Presentation (+CME)
AMP Regular Member: $5.00
AMP Technologist Member: $5.00
AMP Associate Member: $5.00
Non-member Price: $205.00